XML 59 R49.htm IDEA: XBRL DOCUMENT

Contingent consideration (Tables)

12 Months Ended

Jun. 30, 2025

Statement [line items]

Summary of liabilities - contingent consideration


		2025 A$’000				2024 A$’000
Current Liabilities
Contingent consideration - EVT801			—				3,253
			—				3,253

Non-current Liabilities
Contingent consideration - Paxalisib			—				1,266
Contingent consideration - EVT801			—				2,486
			—				3,752
			—				7,005

Summary of reconciliation of contingent consideration


		2025				2024
		A$’000				A$’000
Contingent consideration at start of period (current and non-current)			7,005				6,871
Interest on unwinding of discount			232				339
Foreign currency loss / (gain)			317				(86	)
Gain on remeasurement of contingent consideration			(7,554	)			(119	)

			—				7,005